These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6960739)
21. A one-step monoclonal antibody typing procedure that simplifies HLA class I and class II typing. Lee JH; Lias M; Deng CT; Etessami S; Loon J; Chen M; Banh L; Conger N; Connors D; Manzo A Tissue Antigens; 1994 Jul; 44(1):34-42. PubMed ID: 7974466 [TBL] [Abstract][Full Text] [Related]
22. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis. Yamaguchi M; McSweeney PA; Kimball L; Gersuk G; Hong DS; Kwok W; Storb R; Beckham C; Deeg HJ Transplantation; 1999 Oct; 68(8):1161-71. PubMed ID: 10551646 [TBL] [Abstract][Full Text] [Related]
24. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589 [TBL] [Abstract][Full Text] [Related]
25. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Shaw S; Ziegler A; DeMars R Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497 [TBL] [Abstract][Full Text] [Related]
26. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579 [TBL] [Abstract][Full Text] [Related]
27. Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay. Lemonnier FA; Rebai N; Le Bouteiller PP; Malissen B; Caillol DH; Kourilsky FM J Immunol Methods; 1982 Oct; 54(1):9-22. PubMed ID: 6183366 [TBL] [Abstract][Full Text] [Related]
28. The expression of major histocompatibility antigens on human articular chondrocytes. Lance EM; Kimura LH; Manibog CN Clin Orthop Relat Res; 1993 Jun; (291):266-82. PubMed ID: 7684959 [TBL] [Abstract][Full Text] [Related]
29. Induction of class I and class II antigens during rejection of allografted human hearts. Rose ML; Coles MI; Griffin RJ; Yacoub MH Adv Exp Med Biol; 1985; 186():555-63. PubMed ID: 3901688 [No Abstract] [Full Text] [Related]
30. The characteristics of the HLA antigens determined by cellular techniques. Buc M; Stefanovic J Allerg Immunol (Leipz); 1986; 32(1):19-25. PubMed ID: 2424294 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities. Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258 [TBL] [Abstract][Full Text] [Related]
32. The distribution of HLA antigens on human corneal tissue. Whitsett CF; Stulting RD Invest Ophthalmol Vis Sci; 1984 May; 25(5):519-24. PubMed ID: 6370904 [TBL] [Abstract][Full Text] [Related]
33. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Fuggle SV; Errasti P; Daar AS; Fabre JW; Ting A; Morris PJ Transplantation; 1983 Apr; 35(4):385-90. PubMed ID: 6573052 [TBL] [Abstract][Full Text] [Related]
34. Antigenic composition of human renal vascular endothelium assessed by kidney perfusion. Baldwin WM; Claas FH; van Rood JJ; van Es LA Tissue Antigens; 1984 May; 23(5):256-62. PubMed ID: 6379984 [TBL] [Abstract][Full Text] [Related]
35. [Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy]. Bodem R; Zipperle S; Ho A; Lenhard V Z Kardiol; 1982 Dec; 71(12):820-3. PubMed ID: 6962579 [TBL] [Abstract][Full Text] [Related]
37. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies. Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353 [TBL] [Abstract][Full Text] [Related]
38. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Vartdal F; Gaudernack G; Funderud S; Bratlie A; Lea T; Ugelstad J; Thorsby E Tissue Antigens; 1986 Nov; 28(5):301-12. PubMed ID: 3469787 [TBL] [Abstract][Full Text] [Related]
39. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting. Radka SF; Machamer CE; Cresswell P Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328 [TBL] [Abstract][Full Text] [Related]
40. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation. Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]